SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 60 filers reported holding SUTRO BIOPHARMA INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $2,073,000 | -21.1% | 139,331 | 0.0% | 0.46% | -27.1% |
| Q3 2021 | $2,629,000 | +1.5% | 139,331 | 0.0% | 0.63% | -7.3% |
| Q2 2021 | $2,590,000 | -18.3% | 139,331 | 0.0% | 0.68% | -18.5% |
| Q1 2021 | $3,171,000 | +5.2% | 139,331 | 0.0% | 0.84% | +1.9% |
| Q4 2020 | $3,014,000 | +115.7% | 139,331 | 0.0% | 0.82% | +82.5% |
| Q3 2020 | $1,397,000 | +27.3% | 139,331 | 0.0% | 0.45% | +23.6% |
| Q2 2020 | $1,097,000 | -20.2% | 139,331 | 0.0% | 0.36% | -41.8% |
| Q1 2020 | $1,375,000 | -10.0% | 139,331 | 0.0% | 0.63% | +14.0% |
| Q4 2019 | $1,528,000 | +20.9% | 139,331 | 0.0% | 0.55% | -5.8% |
| Q3 2019 | $1,264,000 | -23.0% | 139,331 | -4.0% | 0.58% | -4.1% |
| Q2 2019 | $1,642,000 | -1.7% | 145,154 | -1.0% | 0.61% | -1.3% |
| Q1 2019 | $1,670,000 | +58.7% | 146,653 | 0.0% | 0.62% | -5.5% |
| Q4 2018 | $1,052,000 | -37.6% | 146,653 | 0.0% | 0.65% | -18.5% |
| Q3 2018 | $1,686,000 | – | 146,653 | – | 0.80% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,675,579 | $13,773,000 | 3.47% |
| AJU IB Investment Co., Ltd. | 175,000 | $1,439,000 | 2.22% |
| Frazier Life Sciences Management, L.P. | 1,776,479 | $14,603,000 | 1.24% |
| First Light Asset Management, LLC | 1,672,497 | $13,748,000 | 1.21% |
| BVF INC/IL | 3,447,946 | $28,342,000 | 1.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,732,400 | $30,680,000 | 0.94% |
| Endurant Capital Management LP | 296,508 | $2,437,000 | 0.64% |
| Parkman Healthcare Partners LLC | 199,846 | $1,643,000 | 0.48% |
| Eventide Asset Management | 2,708,975 | $22,268,000 | 0.35% |
| Lombard Odier Asset Management (Switzerland) SA | 391,024 | $3,214,000 | 0.25% |